BRIEF published on 04/05/2025 at 05:55, 1 year 1 month ago Lobe Sciences Provides Corporate Update on Recent Transactions Clinical Trials Convertible Notes FDA Feedback Lobe Sciences Psilocin Mucate
PRESS RELEASE published on 04/05/2025 at 05:50, 1 year 1 month ago Lobe Sciences Provides Corporate Update Lobe Sciences provides corporate update on recent transactions and business progress including patents and clinical study results. Focus on lipid technology solutions for medical needs Corporate Update Recent Transactions Lobe Sciences Lipid Technology Medical Needs
Published on 05/09/2026 at 01:30, 14 hours 21 minutes ago Star Copper Announces Agreement with Zimtu Capital Corp.
Published on 05/09/2026 at 00:00, 15 hours 51 minutes ago Onco-Innovations Progresses Toward IND Preparation as Nucro-Technics Commences Bioanalysis for PNKP Inhibitor Technology
Published on 05/08/2026 at 20:38, 19 hours 13 minutes ago EQS-Adhoc: thyssenkrupp nucera AG & Co. KGaA: Preliminary Figures for Q2/6M 2025/26; Order Intake Above Expectations and Previous Year ; Sales and Earnings below Market Expectations
Published on 05/08/2026 at 19:12, 20 hours 38 minutes ago EQS-Adhoc: Viromed Medical AG missed revenue forecast for 2025 financial year, but continued to grow significantly and achieved a positive result; revised forecast for 2026
Published on 05/08/2026 at 19:02, 20 hours 49 minutes ago Metall Zug – Annual General Meeting of Shareholders approves all proposals
Published on 05/07/2026 at 19:15, 1 day 20 hours ago 2026 Annual General Meeting: approval of all resolutions submitted to the Meeting
Published on 05/07/2026 at 19:06, 1 day 20 hours ago Disclosure of Share Capital and Voting Rights as of April 30, 2026
Published on 05/07/2026 at 18:17, 1 day 21 hours ago DESCRIPTION OF THE LOUIS HACHETTE GROUP SHARE BUYBACK PROGRAM 2026-2027
Published on 05/07/2026 at 17:45, 1 day 22 hours ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
